Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 7/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | DDX3X | O00571 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14189802 | 1.00 | KCNH3 (0.46) | KCNH3MAPTMEN1KMT2AGAA | |
| SCHEMBL6123868 | 0.97 | MAPT (0.45) | KCNH3MAPTMEN1KMT2AGAA | |
| SCHEMBL7517592 | 0.91 | MAPT (0.53) | KCNH3MAPTMEN1KMT2AGAA | |
| SCHEMBL11936604 | 0.83 | MAPT (0.63) | KCNH3MAPTMEN1KMT2AGAA | |
| SCHEMBL14357408 | 0.83 | MEN1 (0.49) | MAPTMEN1KMT2AGAAMAPK1 | |
| SCHEMBL6123719 | 0.83 | MAPT (0.70) | KCNH3MAPTMEN1KMT2AGAA | |
| SCHEMBL13313311 | 0.83 | MAPT (0.70) | KCNH3MAPTMEN1KMT2AGAA | |
| SCHEMBL12191769 | 0.81 | MAPT (0.41) | KCNH3MAPTMEN1KMT2AGAA | |
| SCHEMBL11923410 | 0.81 | MEN1 (0.41) | KCNH3MAPTMEN1KMT2AGAA | |
| SCHEMBL1401124 | 0.79 | CA12 (0.49) | KCNH3MAPTMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8167991-B2 | Trisazo compound, ink composition, recording method, and colored article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2012-05-01 | — | — | US | disclosed |
| US-7566362-B2 | Ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2009-07-28 | — | — | US | disclosed |
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-03-05 | — | — | US | disclosed |
| US-20090047430-A1 | INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062545-A1 | Trisazo Compound, Ink Composition, Recording Method, and Colored Article | JAK1, TMT1A, CDK1 | KCNH3 304/4885MAPT 2129/4885MEN1 2042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.